Sangamo Inks Deal for New HQ in Bay Area Biotech Hub
Sangamo is moving its corporate headquarters to a new site at Oyster Point in Brisbane, CA. Source: BioSpace
How Sweet It Is: Dynavax Finally Wins FDA OK for Hep B Vaccine Heplisav
The FDA approved Dynavax's Heplisav-B, it's first new hepatitis B vaccine in the U.S. in more than 25 years. Source: BioSpace
As the IDO Battle Gets Ugly, Bristol-Myers Shows Off Early Data for Combo Trial
BMS is pushing forward with its internal IDO1 program and showing off early-stage data from its Phase I/IIa combination trial of Opdivo plus BMS-986205, an IDO1 inhibitor. Source: BioSpace
Siemens to Replace Healthineers CFO in Preparation for Listing
The public listing that is expected to value the business at around $46 billion. Source: BioSpace
This is the Average Interview Process Time for a Biopharma Job
How long does it take to go from application to job offer at a typical life sciences company? Source: BioSpace
Bay Area's Principia Biopharma Scores $765M MS Licensing Deal With Drug Giant Sanofi
Sanofi will write a check for $40 million upfront. Source: BioSpace
GlaxoSmithKline's Pain in China is AstraZeneca's Gain
China revenue in Q3 increased by 12 percent at AstraZeneca and the country now accounts for 15 percent of its global product sales. Source: BioSpace
Sage Therapeutics Stock Rockets on Two Positive Phase III Trials in Postpartum Depression
The positive results support the company's planned regulatory submissions. Source: BioSpace
GlaxoSmithKline Poaches New CSO From Google's Calico
Dr Barron was Executive VP, Head of Global Product Development, and CMO of Roche, responsible for all the products in the combined portfolio of Roche and Genentech. Source: BioSpace
Recipharm to End Operations at Two Swedish Facilities, 225 Employees Affected
The company will explore opportunity to close facilities during second half of 2019. Source: BioSpace
- Go to the previous page
- 1
- …
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- …
- 288
- Go to the next page